enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Stasis dermatitis - Wikipedia

   en.wikipedia.org/wiki/Stasis_dermatitis

   Stasis dermatitis. Stasis dermatitis refers to the skin changes that occur in the leg as a result of "stasis" or blood pooling from insufficient venous return; the alternative name of varicose eczema comes from a common cause of this being varicose veins. [2] Insufficient venous return results in increased pressure in the capillaries with the ...

3. Dermatitis - Wikipedia

   en.wikipedia.org/wiki/Dermatitis

   245 million in 2015 [6] (3.34% of world population) Dermatitis is a term used for different types of skin inflammation, typically characterized by itchiness, redness and a rash. [1] In cases of short duration, there may be small blisters, while in long-term cases the skin may become thickened. [1] The area of skin involved can vary from small ...

4. Id reaction - Wikipedia

   en.wikipedia.org/wiki/Id_reaction

   Id reactions (also known as disseminated eczema[1] and generalized eczema[1]) are types of acute dermatitis developing after days or weeks at skin locations distant from the initial inflammatory or infectious site. They can be localised or generalised. [2][3] This is also known as an autoeczematous response[4] and there must be an identifiable ...

5. EBGLYSS for eczema: What to know about the newly FDA ... - AOL

   www.aol.com/ebglyss-eczema-know-newly-fda...

   A newly approved drug for the treatment of atopic dermatitis could make a big difference to people with moderate-to-severe eczema. Image credit: Sascha Lotz/picture alliance via Getty Images.

6. 7 Eczema Types: What to Know About the Symptoms, Causes ... - AOL

   www.aol.com/lifestyle/7-eczema-types-know...

   Treatment “Mild cases may be managed with frequent thick moisturizing and use of topical medications, while more severe cases can require the same in addition to phototherapy or systemic ...

7. Eli Lilly Scores FDA Approval For Eczema Treatment Ebglyss - AOL

   www.aol.com/eli-lilly-scores-fda-approval...

   Friday, the FDA approved Eli Lilly And Co’s (NYSE:LLY) Ebglyss (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for adults and children 12 years of age and older who weigh at least 88 pounds (40 ...